Advertisement
  • Recognizing AI’s Potential

    Pathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.

    by Stephen Ornes

  • Policy Matters

    Putting an End to Cancer Health Disparities

    Cancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.

    by Michael A. Caligiuri, MD

  • Forward Look

    From Cold Virus to Cancer Fighter

    Neurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.

    by Sue Rochman

  • What Older Patients Value

    Many older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.

    by Cheryl Platzman Weinstock

  • Omitting Obesity

    Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.

    by Cici Zhang

  • Measuring Your Movement

    Researchers are exploring whether wearable personal activity monitors could provide doctors with a more complete picture of cancer patients' well-being.

    by Brad Jones

  • Men Less Likely to Get Genetic Testing

    A study suggests women are more likely than men to undergo genetic testing for mutations linked to hereditary cancer.

    by Cheryl Platzman Weinstock

  • The Ins and Outs of Tumor Testing

    In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.

    by Kate Yandell

  • A Response to Roadblocks

    The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.

    by Kevin McLaughlin

  • Non–Small Cell Lung Cancer Takes Center Stage

    A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.

    by Brad Jones